Arcus Biosciences, Inc.
NYSE RCUS · Hayward, CA
Works in Cardiovascular · Dermatology · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Oncology · Renal & urogenital · Respiratory · Women's health
Arcus Biosciences, Inc. is a clinical trial sponsor based in Hayward, CA, listed as NYSE RCUS. It has 8 active clinical trials with 2,379 planned participants, across 11 therapeutic areas. Since 2021 it has completed 24 trials and stopped 0 early.
Trial track record · since 2021
Financials · NYSE RCUS
Fundraising
Pipeline · 8 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Arcus Biosciences, Inc
Arcus Biosciences, Inc is lead sponsor of 8 active clinical trials on ClinicalTrials.gov, with 2,379 planned participants, in Cardiovascular, Dermatology, GI & liver, Hematology and other areas. Since 2021 it has completed 24 trials and stopped 0 early.
Arcus Biosciences, Inc is based in Hayward, CA and is listed as NYSE RCUS. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Arcus Biosciences, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-09.
Approve Suite is not affiliated with Arcus Biosciences, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.